Investigation of Lymph Node Biology in Kidney Cancer

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorYale University

About this trial

The purpose of this pilot study is to investigate the phenotype, anti-tumor effector functions, and TCR repertoire of T cells isolated from patient tumor draining lymph nodes (TDLNs) to understand T cell priming and trafficking patterns in Renal Cell Carcinoma (RCC). Data and biospecimen collected will be used for current and future research projects involving the study of kidney cancer biology and related medical conditions. Investigators will use this valuable resource to ask clinically relevant translational questions that pertain to biomarker discovery/validation, identification of novel therapeutic targets, and to better understand the genetic and biological basis of the various kidney cancers.

Eligibility criteria

Qualifiers

None

Disqualifiers

Participants under the age of 18. Children will not be enrolled on the study.

Participants known to be pregnant or actively breastfeeding.

Iodine allergy hypersensitivity.

Trial design

Treatments tested in this trial

  • Peripheral Blood Sample for Immune Analysis
  • Tumor Sample for Analysis
  • Adjacent non-malignant kidney for analysis
  • Draining lymph node(s) for analysis
  • Regional non-draining lymph node(s) for analysis

Treatment groups

33 Participants
are divided into 1 treatment group

Sponsors and collaborators